255 related articles for article (PubMed ID: 17614337)
21. Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study.
Sahmoun AE; Case LD; Chavour S; Kareem S; Schwartz GG
Anticancer Res; 2004; 24(5B):3115-20. PubMed ID: 15510598
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
[TBL] [Abstract][Full Text] [Related]
23. Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stage.
Heigener DF; Manegold C; Jäger E; Saal JG; Zuna I; Gatzemeier U
Am J Clin Oncol; 2009 Feb; 32(1):61-4. PubMed ID: 19194127
[TBL] [Abstract][Full Text] [Related]
24. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study.
van Oosterhout AG; van de Pol M; ten Velde GP; Twijnstra A
Cancer; 1996 Apr; 77(8):1434-41. PubMed ID: 8608526
[TBL] [Abstract][Full Text] [Related]
25. [Metastatic spinal cord compression in patients with lung cancer].
Bach F; Agerlin N; Sørensen JB; Bøge-Rasmussen T; Dombernowsky P; Sørensen PS; Hansen HH
Ugeskr Laeger; 1996 Sep; 158(40):5606-10. PubMed ID: 8966788
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
27. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
28. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
29. Brain metastases. Histology, multiplicity, surgery, and survival.
Nussbaum ES; Djalilian HR; Cho KH; Hall WA
Cancer; 1996 Oct; 78(8):1781-8. PubMed ID: 8859192
[TBL] [Abstract][Full Text] [Related]
30. A 20-year retrospective study of small-cell carcinomas in Taiwan.
Li AF; Hsu HS; Hsu CY; Li AC; Li WY; Liang WY; Chen JY
J Surg Oncol; 2010 Oct; 102(5):497-502. PubMed ID: 20872953
[TBL] [Abstract][Full Text] [Related]
31. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Gong M
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
[TBL] [Abstract][Full Text] [Related]
32. Limited-stage extrapulmonary small cell carcinoma: outcomes after modern chemotherapy and radiotherapy.
Soto DE; Eisbruch A
Cancer J; 2007; 13(4):243-6. PubMed ID: 17762759
[TBL] [Abstract][Full Text] [Related]
33. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
34. Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
Pujol JL; Breton JL; Gervais R; Tanguy ML; Quoix E; David P; Janicot H; Westeel V; Gameroff S; Genève J; Maraninchi D
J Clin Oncol; 2007 Sep; 25(25):3945-51. PubMed ID: 17761978
[TBL] [Abstract][Full Text] [Related]
35. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
36. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
[TBL] [Abstract][Full Text] [Related]
37. Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.
Yonemori K; Sumi M; Fujimoto N; Ito Y; Imai A; Kagami Y; Ikeda H
Cancer; 2005 Aug; 104(4):811-6. PubMed ID: 15973666
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
[TBL] [Abstract][Full Text] [Related]
39. Leptomeningeal metastases from small cell lung carcinoma.
Seute T; Leffers P; ten Velde GP; Twijnstra A
Cancer; 2005 Oct; 104(8):1700-5. PubMed ID: 16080173
[TBL] [Abstract][Full Text] [Related]
40. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
